Form 4: iRhythm CFO Sells Shares Under 10b5-1 Plan

iRhythm Technologies' CFO, Daniel G. Wilson, sold 8,000 shares of common stock for $207.44 per share pursuant to a pre-arranged trading plan.

Summary

• Daniel G. Wilson, Chief Financial Officer of iRhythm Technologies, Inc. (IRTC), reported a sale of common stock.
• The transaction involved the disposition of 8,000 shares of iRhythm Technologies common stock.
• The shares were sold at a price of $207.44 per share.
• The sale occurred on October 31, 2025.
• This transaction was executed under a Rule 10b5-1 trading plan established on November 14, 2024.
• Following the sale, Mr. Wilson directly beneficially owns 26,470 shares of common stock.
• Additionally, Mr. Wilson indirectly owns 100 shares through The Wilson Living Trust dated July 9, 2015, of which he is the Trustee.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled insider stock sale under a Rule 10b5-1 plan, which is a routine financial planning event and does not inherently indicate positive or negative company performance or outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

Insider transactions, particularly those executed under pre-arranged 10b5-1 plans, are common in the industry as executives manage personal financial planning, diversification, and liquidity needs. Such planned sales are generally not indicative of a change in company fundamentals or management's outlook.

Related Party Transactions

• Daniel G. Wilson indirectly holds 100 shares through The Wilson Living Trust dated July 9, 2015, of which he is the Trustee.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in direct insider ownership, but as it was pre-planned, it is unlikely to signal a change in management's confidence or company prospects.

Key Dates

Keywords

iRhythm Technologies, IRTC, Form 4, Insider Transaction, Stock Sale, Daniel G. Wilson, CFO, 10b5-1 Plan